We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Celecoxib

Celecoxib | CAS NO: 169590-42-5,Celecoxib is commonly prescribed to relieve pain and inflammation associated with osteoarthritis, a condition where the cartilage in joints breaks down, causing pain and stiffness. Celecoxib can be used for short-term relief of moderate pain, including pain from surgery or injury.

We are the Synchemia Research Chemical specializes in manufacturing and supplying of Celecoxib impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities It is also used to treat rheumatoid arthritis, an autoimmune condition where the body's immune system attacks the joints, leading to inflammation, pain, and potential joint damage. Buy Reliable and High-Purity Celecoxib Impurities, Delivered by Synchemia Research Chemicals.

download image Download catalogue

Pharmaceutical Reference Standards

Celecoxib Impurity 13
Celecoxib Impurity 13
CAT No SRC-C33274
CAS No NA
Mol.F. C11H9F3O3
Mol.Wt. 246.2g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Impurity 14
Celecoxib Impurity 14
CAT No SRC-C33275
CAS No 36326-86-0
Mol.F. C6H6N4O2S
Mol.Wt. 198.2g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Impurity 15
Celecoxib Impurity 15
CAT No SRC-C33276
CAS No 1576-43-8
Mol.F. C6H7NO3S
Mol.Wt. 173.2g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Impurity 16
Celecoxib Impurity 16
CAT No SRC-C33277
CAS No 53764-99-1
Mol.F. C11H9F3O2
Mol.Wt. 230.2g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Impurity 17
Celecoxib Impurity 17
CAT No SRC-C33278
CAS No 75877-78-0
Mol.F. C6H4ClN2
Mol.Wt. 139.6g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Impurity 20
Celecoxib Impurity 20
CAT No SRC-C33279
CAS No NA
Mol.F. C17H15F3N2O3S
Mol.Wt. 384.4g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Impurity 21
Celecoxib Impurity 21
CAT No SRC-C33280
CAS No 2247197-66-4
Mol.F. C18H15F3N2O3S
Mol.Wt. 396.4g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Impurity 22
Celecoxib Impurity 22
CAT No SRC-C33281
CAS No 2247197-67-5
Mol.F. C19H17F3N2O3S
Mol.Wt. 410.4g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Impurity 23
Celecoxib Impurity 23
CAT No SRC-C33282
CAS No 2247197-65-3
Mol.F. C17H14F3N3O4S
Mol.Wt. 413.4g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Impurity 24
Celecoxib Impurity 24
CAT No SRC-C33283
CAS No 90829-71-3
Mol.F. C6H7N3O2S
Mol.Wt. 185.2g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Impurity 25
Celecoxib Impurity 25
CAT No SRC-C33284
CAS No 877-67-8
Mol.F. C6H8N2O3S
Mol.Wt. 188.2g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Impurity 26
Celecoxib Impurity 26
CAT No SRC-C33285
CAS No 4392-39-6
Mol.F. C12H13N5O4S2
Mol.Wt. 355.4g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Impurity 28
Celecoxib Impurity 28
CAT No SRC-C33286
CAS No 121-52-8
Mol.F. C6H6N2O4S
Mol.Wt. 202.2g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Impurity 29
Celecoxib Impurity 29
CAT No SRC-C33287
CAS No 138-42-1
Mol.F. C6H5NO5S
Mol.Wt. 203.2g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Impurity 30
Celecoxib Impurity 30
CAT No SRC-C33288
CAS No 131774-72-6
Mol.F. C6H9N3O2S
Mol.Wt. 187.2g/mole
INV STATUS CUSTOM SYNTHESIS
Celecoxib Related Compound 4
Celecoxib Related Compound 4
CAT No SRC-C33289
CAS No 720-94-5
Mol.F. C11H9F3O2
Mol.Wt. 230.2g/mole
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.